Data on temporal changes in alcoholic liver disease (ALD)-related mortality in the United States are lacking. This longitudinal assessment is important, given the divergent data on trends in worldwide ALD-related mortality, concerns for underestimation of mortality attributed to ALD in previous investigations, and shifting attention to hepatitis C virus (HCV)-related mortality.
INTRODUCTION
Alcohol-related liver disease (ALD) is a signifi cant burden on health, with alcohol consumption accounting for an estimated 3.8 % of global mortality ( 1 ) . In 1997, ALD was responsible for 40 % of all deaths from cirrhosis and 28 % of all deaths from liver disease ( 2 ) . However, data on temporal changes in ALD-related death rate in the United States are lacking.
An accurate characterization of these trends is important for many reasons. First, although mortality from alcohol-related cirrhosis shows favorable trends in most countries of the world, an alarming increase in mortality has been observed in the United Kingdom and certain European countries ( 3 ) . Whether-ALD related mortality continues to decline in the United States in the context of high-risk drinking patterns and uniformly for all racial groups is unknown. For example, an estimated 28 % of adults engage in binge drinking, which has been associated with alcoholic hepatitis ( 4, 5 ) .
Whether such maladaptive consumption patterns lead to excess ALD-related deaths is not known. In addition, whether racial disparities still exist in trends in ALD-related mortality for minority race groups is not well described ( 6 ) . Th is information is important to focus preventive eff orts in subgroups of the population that are at the highest risk for ALD. Second, current data may underestimate the mortality attributed to ALD ( 6 ) . Analysis of death rate attributed to liver cirrhosis by the NIAAA (National Institute on Alcohol Abuse and Alcoholism) only takes into account a single underlying cause of death and does not account for signifi cant conditions that may still be related to alcohol (e.g., portal hypertension). Th ird, there are limited data comparing trends in ALD-related mortality and hepatitis C virus infection (HCV)-related mortality. As alcohol and hepatitis C are the two most common causes of liver disease, comparing mortality trends in these two groups would be helpful to gauge the relative contribution of ALD-related mortality ( 7 ).
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Finally, longitudinal assessment of the eff ect of concurrent ALD and HCV (ALD / HCV) is lacking.
To address these concerns, we examined the temporal changes in mortality related to ALD and HCV from 1980 to 2003, using publicly available mortality data with the hypothesis that alcohol continues to be a signifi cant cause of liver-related mortality when compared with HCV. We examined the death rate stratifi ed by diagnosis (ALD, HCV, or ALD / HCV) over the time period and assessed the eff ect of age and race on mortality trends.
METHODS

Data source
Mortality data were collected from the multiple cause-of-death public-use data fi le from the National Vital Statistics System from 1980 to 2003. Th is data fi le includes individual death certifi cates for all resident deaths from the 50 states and the District of Columbia ( 8 ). Information regarding age (5-year increments), sex, race (African American, Caucasian, and " other " ), place of birth, and death is available. Th e standard death certifi cates were extracted for information in part I of the certifi cate, which records the " immediate " or " underlying " causes of death. Information from part II, which includes information on other " signifi cant conditions contributing to death but not resulting in the underlying cause given in Part I, " was not extracted, given that ALD or HCV may have been incidentally present in a person who died from an unrelated cause (e.g., myocardial infarction).
Case ascertainment
We identifi ed all death certifi cates with ALD, HCV, or both as potential causes of death. Medical conditions recorded in multiple cause-of-death data were coded from 1980 to 1998 in accordance with the International Classifi cation of Diseases, ninth revision (ICD-9), and from 1999 to 2003 in accordance with the International Classifi cation of Diseases, tenth revision (ICD-10). Diff erences in the terms referenced refl ect changes in nomenclature from ICD-9 to ICD-10 for ALD and HCV.
We only included cases in which any of the diagnoses of interest were mentioned in part I of the certifi cate (immediate or underlying). All patients with either alcoholic hepatitis (ICD-9 code 571.1 or ICD-10 code K70.1) or alcoholic cirrhosis (ICD-9 code 571.2 or ICD-10 code K70.3) were retrieved. However, it is possible that death related to ALD may be incorrectly coded. To increase ascertainment, we identifi ed all death certifi cates with alcohol indicated as a cause (e.g., unspecifi ed alcoholic liver damage, ICD-9 code 571.3) and a liver diagnosis of interest (e.g., portal hypertension, ICD-9 code 572.3). Diagnostic testing for HCV was available in 1991 and therefore HCV-related deaths were obtained from 1991 to 2003. Data regarding age, gender, and race (African American, Caucasian, and " other " ) were also extracted.
Data analysis
First, we compared the baseline characteristics at the time of death based on diagnoses at death: ALD alone, HCV alone, or both ALD and HCV (ALD / HCV). Only these deaths for subjects of ≥ 15 years were included in the analyses. We also calculated the percentage of deaths due to alcoholic hepatitis ( 4 ). Second, mortality (incidence rates of death) attributable to ALD or HCV or both diagnoses (ALD / HCV) was calculated considering the entire population of the United States at risk. We examined trends in death rates over the 24-year study period by adjusting denominator age-and sex-specifi c person-years to the year 2000 US census data. Finally, we calculated age-specifi c trends (by decade starting at age 15) and age-and sex-adjusted rates by race (African American, Caucasian, and " other " ) for ALD-related mortality.
RESULTS
Decedent characteristics
From 1980 to 2003 ( Table 1 ), a total of 287,365 deaths were attributable to ALD ( n = 234,357), HCV ( n = 49,801), and concomitant ALD / HCV ( n = 3,207). In total, the median age at death was 55 years and the majority of decedents were male (71.2 % ) and Caucasian 
Temporal changes in ALD and HCV mortality
Of all reported ALD-related deaths, deaths attributed to alcoholic hepatitis changed from 8.5 % between 1980 and 1984 to 9.5 % between 1990 and 1994 and to 8.7 % between 1999 and 2003 ( Table 1 ). Figure 2 shows the temporal changes in death rate attributed to ALD and HCV. Age-and sex-adjusted ALD-related mortality (per 100,000 persons) decreased from 6.9 in 1980 to 4.6 in 1998 and 4.4 in 2003. HCV diagnostic testing was introduced in 1991. Overall hepatitis C-related age-and sex-adjusted mortality rose to 2.1 in 1998 and 2.9 in 2003. Death rates in the combined ALD / HCV group remained fairly constant from 1999 to 2003 (0.2 / 100,000 persons for both years). Figure 3 examines the change in sex-adjusted mortality related to ALD by age groups, starting at age 15. ALD-related mortality was highest in the ages 45 -54 years, followed by 55 -64 years and remained relatively unchanged over the 24-year period. Agespecifi c mortality (per 100,000 persons) was 1.5 and 1.1 for ages 45 -54 and 55 -64 years in 2003, respectively.
Age-specifi c changes in ALD-related mortality
Race-specifi c differences in ALD-related mortality
We examined the change in age-and sex-adjusted mortality related to ALD stratifi ed by race ( Figure 4 ) . Overall, ALD-related Paula et al.
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mortality decreased for all races. Th e age-and sex-adjusted ALDrelated mortality (per 100,000 persons) among Caucasians was 6. 
DISCUSSION
Given the divergent data on worldwide ALD-related deaths, we analyzed mortality data from the National Vital Statistics System from 1980 to 2003 ( 3, 9 ) . Several important observations are evident from our study. ALD remains one of the most important causes of liver-related death in the United States. In 2003, mortality rates were 4.4 / 100,000 for ALD when compared with 2.9 / 100,000 for HCV. As of 2003, ALD-related mortality aff ected the three race categories similarly. Finally, patients with concomitant ALD / HCV may be at risk for death at an earlier age. 
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ALD-related mortality continues to be a signifi cant contributor of liver-related mortality, despite a decline in observed death rate from 6.9 / 100,000 persons in 1980 to 4.4 / 100,000 persons in 2003. Th ese trends parallel the reported decline in death rate from liver cirrhosis (any cause) as reported by the NIAAA (15.1 / 100,000 persons in 1980 to 9.2 / 100,000 persons in 2003) ( 6 ) . Th e decline in ALD-related mortality may be because of several possibilities: decrease in alcohol consumption, improved medical interventions that aff ect the natural history of disease, or misclassifi cation of cases. Per capita alcohol consumption declined from 1980 to 1998 and the plateau in ALD mortality observed in recent years may be refl ective of that change ( 10 ) . In addition, participation in Alcoholics Anonymous and liver transplantation for ALD have both been associated with improved survival ( 11 -13 ) . Alternatively, it is also possible that liver-related deaths were incorrectly attributed to alcohol rather than chronic hepatitis C infection. When hepatitis C serology testing was introduced in the early 1990s, a rapid increase in HCV-related deaths was observed ( 14 ) . Th erefore, it is possible that alcohol-related mortality may have remained at a constant rate throughout the 1980s and 1990s, but HCV-related deaths may have been mistakenly classifi ed as alcohol related, leading to the apparent decline.
A plateau in the death rate, however, should not provide false assurance. First, although eff orts at preventing alcoholic cirrhosis may have improved, the decrease in the median age at death observed in our study is concerning. Second, although the rates of deaths related to alcoholic hepatitis did not increase over the 24-year period (consistent with a recent independent analysis ( 15 )), this may provide an incomplete picture. Alcoholic hepatitis is oft en misdiagnosed by physicians and by coding specialists and the true burden of alcoholic hepatitis-related deaths may be underestimated ( 4 ) . Th ird, quantity, frequency, and pattern of alcohol consumption are all signifi cant determinants of ALD ( 5 ). Th ere has been a recent increase in alcohol consumption (1999 -2006) likely that alcohol-related injury will increase ( 18 ) . In alco holics, predictors for developing liver fi brosis and cirrhosis include obesity and hyperglycemia ( 18 ) . Obesity potentiates the severity of ALD in all its stages, including fatty liver, alcoholic steatohepatitis, and cirrhosis ( 19 ) . Although one would hope that a further decline in ALD-related mortality would be observed in the coming years, the contribution of high-risk drinking patterns, the recent increase in alcohol consumption, and the epidemic of obesity needs to be examined ( 20 ) . With regard to the racial breakdown of ALD mortality, our data showed that African-Americans ' rate was nearly twice that of Caucasians and " other " race counterparts until the early 1990s, when it started a decrease to a level comparable to others. At least a part of the explanation for this observation is reclassifi cation of hepatitis C cases, as the burden of HCV among African Americans is much higher than others. Whether other factors, such as trends in alcohol consumption, contributed to this trend remains unknown. With regard to the " other " group, we found that rates of ALD-related mortality were lower compared with previous reports. Previous studies have shown that certain minority race groups within the " other " group have a higher mortality. For example, Vong and Bell ( 14 ) showed that in 1998, mortality due to chronic liver disease among American Indian and Alaska Natives was more than twice those of African Americans and Caucasians.
Our study had several strengths. First, we analyzed a comprehensive data source over 24 years with a large number of subjects. Previous analyses of similar data sets have been limited by the time period under study or underestimation of the true disease burden ( 2, 6, 9, 14 ) . We decreased ascertainment bias by examining alcohol and HCV as the immediate and underlying cause of death as well as incorporating a more comprehensive defi nition of ALD-related mortality. We expanded on a previous estimation of chronic liver disease by including more recent data (1999 -2003 ) that used ICD-10 diagnostic coding system ( 14 ) .
However, our study may have limitations as well. We may have underestimated the true mortality from ALD or HCV. Alcohol or HCV-related diagnoses may have been underreported on death certifi cates ( 21 -23 ) . However, the inclusion of death certifi cates listing manifestations of end-stage liver disease potentially attributed to alcohol minimizes the eff ect of underreporting. Although the revision from ICD-9 to ICD-10 in 1998 was contemplated as a factor for altering the diagnosis for causes of death, the comparability ratio (the ratio of the number of deaths coded to a cause in ICD-10 to the number coded to the equivalent cause in ICD-9) for chronic liver diseases and cirrhosis changed by only 4 % since implementation of ICD-10 ( 24 ). Hence, the sudden change in ICD coding would not substantially infl uence the results.
In summary, our study shows that ALD remains an important cause of mortality. Despite the recent attention given to HCV as a signifi cant cause of death and despite encouraging trends in ALDrelated mortality, the pervasive eff ect of alcohol as a signifi cant cause of liver-related deaths will require continued attention.
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